A Molecular and Epidemiological Investigation of a Large SARS-CoV-2 Outbreak in a Long-Term Care Facility in Luxembourg, 2021
- PMID: 36826361
- PMCID: PMC9957261
- DOI: 10.3390/geriatrics8010019
A Molecular and Epidemiological Investigation of a Large SARS-CoV-2 Outbreak in a Long-Term Care Facility in Luxembourg, 2021
Abstract
In spring 2021, a long-term care facility (LTCF) of 154 residents in Luxembourg experienced a large severe, acute respiratory-syndrome coronavirus 2 (SARS-CoV-2) outbreak a few days after a vaccination campaign. We conducted an outbreak investigation and a serosurvey two months after the outbreak, compared attack rates (AR) among residents and staff, and calculated hospitalization and case-fatality rates (CFR). Whole genome sequencing (WGS) was performed to detect variants in available samples and results were compared to genomes published on GISAID. Eighty-four (55%) residents and forty-five (26%) staff members tested positive for SARS-CoV-2; eighteen (21%) residents and one (2.2%) staff member were hospitalized, and twenty-three (CFR: 27%) residents died. Twenty-seven (21% of cases) experienced a reinfection. Sequencing identified seventy-seven cases (97% of sequenced cases) with B.1.1.420 and two cases among staff with B.1.351. The outbreak strain B.1.1.420 formed a separate cluster from cases from other European countries. Convalescent and vaccinated residents had higher anti-SARS-CoV-2 IgG antibody concentrations than vaccinated residents without infection (98% vs. 52%, respectively, with >120 RU/mL, p < 0.001). We documented an extensive outbreak of SARS-CoV-2 in an LTCF due to the presence of a specific variant leading to high CFR. Infection in vaccinated residents increased antibody responses. A single vaccine dose was insufficient to mitigate the outbreak.
Keywords: COVID-19; SARS-CoV-2; antibodies; elderly; infection control; mortality; nursing home; outbreak; public health; whole genome sequencing.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Bialek S., Boundy E., Bowen V., Chow N., Cohn A., Dowling N., Ellington S., Gierke R., Hall A., MacNeil J., et al. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19)—United States, February 12–March 16, 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:343–346. doi: 10.15585/mmwr.mm6912e2. - DOI - PMC - PubMed
-
- Graham N.S.N., Junghans C., Downes R., Sendall C., Lai H., McKirdy A., Elliott P., Howard R., Wingfield D., Priestman M., et al. SARS-CoV-2 Infection, Clinical Features and Outcome of COVID-19 in United Kingdom Nursing Homes. J. Infect. 2020;81:411–419. doi: 10.1016/j.jinf.2020.05.073. - DOI - PMC - PubMed
-
- Burton J.K., Bayne G., Evans C., Garbe F., Gorman D., Honhold N., McCormick D., Othieno R., Stevenson J.E., Swietlik S., et al. Evolution and Effects of COVID-19 Outbreaks in Care Homes: A Population Analysis in 189 Care Homes in One Geographical Region of the UK. Lancet Healthy Longev. 2020;1:e21–e31. doi: 10.1016/S2666-7568(20)30012-X. - DOI - PMC - PubMed
-
- Patel M.C., Chaisson L.H., Borgetti S., Burdsall D., Chugh R.K., Hoff C.R., Murphy E.B., Murskyj E.A., Wilson S., Ramos J., et al. Asymptomatic SARS-CoV-2 Infection and COVID-19 Mortality During an Outbreak Investigation in a Skilled Nursing Facility. Clin. Infect. Dis. 2020;71:2920–2926. doi: 10.1093/cid/ciaa763. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
